Adolore Biotherapeutics, Inc.

BRIEF

published on 10/02/2024 at 16:05, 2 months 18 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

Adolore BioTherapeutics Chronic Pain Treatments Opioid Alternatives 18th Annual Pain Therapeutics Summit CA8* Analgesic Peptides
PRESS RELEASE

published on 10/02/2024 at 16:00, 2 months 18 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology

Adolore BioTherapeutics Opioid-free Chronic Pain Treatments CA8 Peptides RdHSV Vectors
BRIEF

published on 09/24/2024 at 14:25, 2 months 26 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event

Adolore BioTherapeutics Chronic Pain Non-opioid Therapy BioSparkVA Roy C. Levitt
PRESS RELEASE

published on 09/24/2024 at 14:20, 2 months 26 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
Adolore BioTherapeutics to present innovative opioid-free chronic pain therapy at BioSpark Pitch Event. Programs for knee osteoarthritis & erythromelalgia in development

Adolore BioTherapeutics Chronic Pain Opioid-free Biotherapeutics Innovative Therapy
BRIEF

published on 07/30/2024 at 14:15, 4 months 21 days ago

Adolore BioTherapeutics Publishes Promising Preclinical Data on Non-Opioid Analgesic Gene Therapy

Adolore BioTherapeutics Chronic Pain Gene Therapy Osteoarthritis Non-opioid Analgesic
PRESS RELEASE

published on 07/30/2024 at 14:10, 4 months 21 days ago

Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Adolore BioTherapeutics validates a non-opioid analgesic gene therapy for chronic pain via local delivery to sensory neurons. Preclinical study supports opioid-free treatment for chronic knee pain due to OA

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesic Opioid-free Treatment
BRIEF

published on 06/10/2024 at 15:20, 6 months 10 days ago

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference

Adolore BioTherapeutics Opioid-free Gene Therapy Chronic Pain Treatment Virtual Investor Pitch Conference
PRESS RELEASE

published on 06/10/2024 at 15:15, 6 months 10 days ago

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
Adolore BioTherapeutics to present at Virtual Investor Pitch Conference on June 17, 2024, 10:00 AM ET. CEO Roelof Rongen to provide an elevator pitch on breakthrough opioid-free gene therapy treatments for chronic pain

Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy Virtual Investor Pitch Conference
BRIEF

published on 05/21/2024 at 16:05, 6 months 30 days ago

Adolore BioTherapeutics Unveils Strategy for Non-Opioid Analgesic Gene Therapies

Adolore BioTherapeutics Chronic Pain Gene Therapy Clinical Studies Non-opioid Analgesic
PRESS RELEASE

published on 05/21/2024 at 16:00, 6 months 30 days ago

Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the Treatment of Chronic Pain
Adolore BioTherapeutics outlines pipeline development progress and business outlook focused on breakthrough gene therapy treatments for chronic pain, funded by NIH grant

Adolore BioTherapeutics Chronic Pain Gene Therapy Pipeline Development NIH Grant

Published on 12/21/2024 at 01:30, 12 hours 19 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 19 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 44 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 49 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 19 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 58 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 4 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 39 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 53 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 49 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 32 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 49 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 54 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 49 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News